Human immunodeficiency virus (HIV) vaccine trials: a novel assay for differential diagnosis of HIV infections in the face of vaccine-generated antibodies
about
HIV vaccine-induced sero-reactivity: a challenge for trial participants, researchers, and physiciansSafety and immunogenicity study of Multiclade HIV-1 adenoviral vector vaccine alone or as boost following a multiclade HIV-1 DNA vaccine in AfricaAvian influenza pandemic preparedness: developing prepandemic and pandemic vaccines against a moving targetAntigenic fingerprinting of H5N1 avian influenza using convalescent sera and monoclonal antibodies reveals potential vaccine and diagnostic targetsH5N1-SeroDetect EIA and rapid test: a novel differential diagnostic assay for serodiagnosis of H5N1 infections and surveillance.Novel approach for differential diagnosis of HIV infections in the face of vaccine-generated antibodies: utility for detection of diverse HIV-1 subtypesHIV-Selectest enzyme immunoassay and rapid test: ability to detect seroconversion following HIV-1 infection.Phages and HIV-1: from display to interplay.Performance of a redesigned HIV Selectest enzyme-linked immunosorbent assay optimized to minimize vaccine-induced seropositivity in HIV vaccine trial participants.Profiling the IgOme: meeting the challenge.Identification of a conserved linear neutralizing epitope recognized by monoclonal antibody 9A9 against serotype A foot-and-mouth disease virus.
P2860
Q28082836-94E330B3-E74F-4731-8D72-D231CD21E99CQ28749224-7EDA331D-4A7A-4C11-9A57-68BEA26911D2Q30227194-C8A57612-6B2F-4775-952D-8728462AFC09Q30376292-67A46621-6A9A-4FF6-B5FD-F207EC08D64CQ30407593-9B13C37B-1D52-4E62-AE2F-48B2B57614EDQ33259283-CEA63C02-C877-4507-9CEA-F6B5DAB51FBDQ33614208-205415E4-BA76-4A90-AF3D-0DA14EB74A00Q34273397-615BC829-7F7F-4A6D-AAAA-48578813D1EAQ37643303-C2AF5E55-EDFA-4949-933A-A0CD6EAD1FABQ38163241-4EF358DA-CEED-420E-B242-72E002E0459FQ38841363-73BF4F23-64EF-4E8B-8B78-0911BC9F4C3B
P2860
Human immunodeficiency virus (HIV) vaccine trials: a novel assay for differential diagnosis of HIV infections in the face of vaccine-generated antibodies
description
2006 nî lūn-bûn
@nan
2006 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մարտին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Human immunodeficiency virus ( ...... f vaccine-generated antibodies
@ast
Human immunodeficiency virus ( ...... f vaccine-generated antibodies
@en
type
label
Human immunodeficiency virus ( ...... f vaccine-generated antibodies
@ast
Human immunodeficiency virus ( ...... f vaccine-generated antibodies
@en
prefLabel
Human immunodeficiency virus ( ...... f vaccine-generated antibodies
@ast
Human immunodeficiency virus ( ...... f vaccine-generated antibodies
@en
P2093
P2860
P1433
P1476
Human immunodeficiency virus ( ...... f vaccine-generated antibodies
@en
P2093
Andrew T Catanzaro
Bonnie Mathieson
David A Cooper
Hana Golding
Isaac R Rodriguez-Chavez
James Needham
Jan Guerin
Marc Gurwith
Michael L Peterson
Nga Nguyen
P2860
P304
P356
10.1128/JVI.80.5.2092-2099.2006
P577
2006-03-01T00:00:00Z